Fig. 5.
Fig. 5. Schematic diagram for the proteolytic cleavages of human F.V and F.Va by HNE. The domain structure of human F.V is made up of the heavy chain (residues 1-709) comprising two A domains (A1-A2) and connecting regions.3851 The B domain spans residues 710 to 1545 and connects the heavy and light chains. The light chain (residues 1546-2196) is composed of one A and two C domains (A3-C1-C2). The results of the NH2 -terminal sequencing indicated HNE activates human F.V cofactor activity after cleavage at Ile819 and Ile1484 (HNE-labeled light arrows) and inactivates human F.Va cofactor activity after cleaving at Ala341, Ile508, and Thr1767 (HNE-labeled dark arrows). The positions of the HNE cleavage sites within the F.V/F.Va molecule are shown below the cartoon representation of intact F.V, while the thrombin (IIa-labeled light arrows) activation and the Activated Protein C (APC-labeled dark arrows) inactivation cleavage sites are shown above for comparison.

Schematic diagram for the proteolytic cleavages of human F.V and F.Va by HNE. The domain structure of human F.V is made up of the heavy chain (residues 1-709) comprising two A domains (A1-A2) and connecting regions.38 51 The B domain spans residues 710 to 1545 and connects the heavy and light chains. The light chain (residues 1546-2196) is composed of one A and two C domains (A3-C1-C2). The results of the NH2 -terminal sequencing indicated HNE activates human F.V cofactor activity after cleavage at Ile819 and Ile1484 (HNE-labeled light arrows) and inactivates human F.Va cofactor activity after cleaving at Ala341, Ile508, and Thr1767 (HNE-labeled dark arrows). The positions of the HNE cleavage sites within the F.V/F.Va molecule are shown below the cartoon representation of intact F.V, while the thrombin (IIa-labeled light arrows) activation and the Activated Protein C (APC-labeled dark arrows) inactivation cleavage sites are shown above for comparison.

Close Modal

or Create an Account

Close Modal
Close Modal